Literature DB >> 16053195

Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia--an 18-year survey.

Emil Pal1, Franc Strle, Tatjana Avsic-Zupanc.   

Abstract

OBJECTIVE: To determine the etiology of hemorrhagic fever with renal syndrome (HFRS) in the north-eastern part of Slovenia (Pomurje region) together with demographic, epidemiological and clinical data on 25 patients from this region who were diagnosed and treated at the General Hospital in Murska Sobota between 1986 and 2003.
METHODS: Medical records of patients with a discharge diagnosis of HFRS who were either hospitalized or referred to an infectiologist as outpatients were included in this retrospective study. Data on demographic characteristics, clinical manifestations and laboratory parameters were collected from the patients' records. In addition, all available follow-up records were examined and information on general health, blood pressure, basic blood and biochemical examination and urine analysis was collected.
RESULTS: Infection with Puumala virus (PUUV) was indicated in 23 patients and Dobrava virus (DOBV) infection in two patients. The median age of patients was 39 years; 19 were male. The patients primarily had outdoor occupations. Most of the HFRS cases occurred between May and August. The most common findings were fever, vomiting, headache, myalgia, chills, cough, back and abdominal pain, and blurred vision. The most prominent laboratory abnormalities were elevated erythrocyte sedimentation rate and C-reactive protein concentration, thrombocytopenia, and leucocytosis with neutrophilia. The signs of renal dysfunction were observed in 24 of the 25 patients. Oliguric renal failure was seen in 13 of 23 (57%) PUUV-infected patients. Six of 23 (26%) patients infected with PUUV and one of two (50%) patients from the DOBV group had hypotension or developed signs of shock. Seven out of 15 (47%) patients had elevated protein concentration in cerebrospinal fluid (CSF). Sinus bradycardia was documented in 7 of 17 (41%) patients with PUUV infection.
CONCLUSIONS: HFRS is endemic in the north-eastern part of Slovenia; PUUV and DOBV infections coexist, with PUUV being the main causative agent of HFRS. Demographic, clinical and laboratory findings in our patients with HFRS caused by PUUV were mostly in accordance with those published previously, but the ratio of patients with sinus bradycardia, oliguric renal failure and mildly elevated CSF protein concentration was rather high.

Entities:  

Mesh:

Year:  2005        PMID: 16053195     DOI: 10.1007/s00508-005-0359-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  12 in total

1.  Pathogenicity and virulence of the present hantaviruses in Bosnia and Herzegovina: the impact on renal function.

Authors:  M Hukić; A Valjevac; D Tulumovic; F Numanovic; P Heyman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-23       Impact factor: 3.267

2.  Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice.

Authors:  Takaaki Koma; Kumiko Yoshimatsu; Noriyo Nagata; Yuko Sato; Kenta Shimizu; Shumpei P Yasuda; Takako Amada; Sanae Nishio; Hideki Hasegawa; Jiro Arikawa
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

3.  HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients.

Authors:  Misa Korva; Ana Saksida; Sabina Kunilo; Blanka Vidan Jeras; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2011-07-20

Review 4.  Emerging zoonoses and vector-borne infections affecting humans in Europe.

Authors:  R M Vorou; V G Papavassiliou; S Tsiodras
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

5.  Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome.

Authors:  Ana Saksida; Branka Wraber; Tatjana Avšič-Županc
Journal:  BMC Infect Dis       Date:  2011-05-23       Impact factor: 3.090

6.  Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome.

Authors:  Emil Pal; Miša Korva; Katarina Resman Rus; Nataša Kejžar; Petra Bogovič; Anica Kurent; Tatjana Avšič-Županc; Franc Strle
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

7.  Characterization of Biomarker Levels in Crimean-Congo Hemorrhagic Fever and Hantavirus Fever with Renal Syndrome.

Authors:  Miša Korva; Katarina Resman Rus; Miša Pavletič; Ana Saksida; Nataša Knap; Mateja Jelovšek; Katja Strašek Smrdel; Xhevat Jakupi; Isme Humolli; Jusuf Dedushaj; Miroslav Petrovec; Tatjana Avšič-Županc
Journal:  Viruses       Date:  2019-07-26       Impact factor: 5.048

Review 8.  Viral hemorrhagic fevers: current status of endemic disease and strategies for control.

Authors:  Dennis J Cleri; Anthony J Ricketti; Richard B Porwancher; Luz S Ramos-Bonner; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2006-06       Impact factor: 5.982

9.  HMGB1 Is a Potential Biomarker for Severe Viral Hemorrhagic Fevers.

Authors:  Katarina Resman Rus; Luka Fajs; Miša Korva; Tatjana Avšič-Županc
Journal:  PLoS Negl Trop Dis       Date:  2016-06-27

10.  Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.

Authors:  Janice M Rusnak; William R Byrne; Kyung N Chung; Paul H Gibbs; Theodore T Kim; Ellen F Boudreau; Thomas Cosgriff; Philip Pittman; Katie Y Kim; Marianne S Erlichman; David F Rezvani; John W Huggins
Journal:  Antiviral Res       Date:  2008-10-31       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.